News Daily News Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD Yael L. Maxwell March 24, 2026
News Daily News Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis Yael L. Maxwell March 12, 2026
News Daily News HBR Common, Impactful Among All-Comer Acute MI Patients Yael L. Maxwell March 05, 2026
News Daily News Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone Michael O'Riordan March 03, 2026
News Daily News Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis L.A. McKeown February 06, 2026
News Daily News Weight Loss Drugs Show Promise for Secondary Prevention in PAD L.A. McKeown February 04, 2026
News Daily News Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US Caitlin E. Cox January 23, 2026
News Daily News IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis Caitlin E. Cox January 20, 2026
News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER Michael O'Riordan December 12, 2025
News Daily News TAVI Patients Seem to Pay No Penalty for Obstructive CAD Yael L. Maxwell December 09, 2025
News Daily News Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis Yael L. Maxwell October 24, 2025
News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News AI Tool Supports Mammograms as Method to Screen Women for CV Risk Caitlin E. Cox September 18, 2025
News Daily News Evolocumab Gains Expanded Indication for Primary Prevention Michael O'Riordan August 26, 2025